Skip to main content

Table 1 Clinical features of patients with homozygous PTCs in PDZD8

From: Autistic behavior is a common outcome of biallelic disruption of PDZD8 in humans and mice

Characteristic

Family C Affected Individuals

Incidence in all IDDADF cases [2]

C.IV.1

C.IV.2

Consanguinity

Yes

Yes

6/6

Ethnic Origin

Afghan

Afghan

 

Genotype, Mat/Pat

p.(Q30*)/p.(Q30*);

c.88 C > T/c.88 C > T

p.(Q30*)/p.(Q30*);

c.88 C > T/c.88 C > T

 

Sex

Male

Female

 

Age, Years

18

13

 

Developmental Delay

Yes

Yes

6/6

Intellectual Disability

Yes (severe)

Yes (severe)

6/6 (severe: 4/6)

Autism

Yes (ASD)

Yes (ASD)

6/6 (ASD: 5/6)

Facial Dysmorphism

Yes

Yes

6/6

Myasthenia

Yes (mild)

Yes (mild)

5/6 (mild: 3/6)

Epilepsy

Yes

No

3/6

Scoliosis

Yes

No

2/6

Aggression

No

Yes

1/6

Orbital Hypertelorism

No

No

4/6

Myopia

No

No

2/6

Marfanoid Habitus

No

No

2/6

ADHD

No

No

2/6

Brain Scan Findings

Cortico-subcortical demyelinating lesions; mild cerebellar atrophy

Subcortical aspecific gliotic lesions

 
  1. Nucleotide and residue numbering are based on NM_173791.5
  2. ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; IDDADF, intellectual developmental disorder with autism and dysmorphic facies; Mat, maternal; Pat, paternal